Artificial intelligence has crossed a new threshold in biology, helping design viruses that can seek out and kill drug resistant bacteria such as dangerous strains of E. coli. Instead of discovering ...

As antibiotic-resistant "superbugs" make infections trickier to treat, some in the medical community are turning to bacteriophages for backup. Also known as phages, these viruses exclusively target ...

Collateral damage to normal microbiota, which can be associated with the use of less-specific chemical antibacterials, [4] is avoided. Nonetheless, there are several challenges that must be addressed ...

Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 Cystic Fibrosis (CF) Phase 2b trial BiomX continues to see potential in BX011 ...